Literature DB >> 20513005

Carvedilol for portal hypertension in patients with cirrhosis.

Jaime Bosch1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20513005     DOI： 10.1002/hep.23689

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  18 in total

Review 1.  Pathophysiology of portal hypertension and its clinical links.

Authors:  Yeon Seok Seo; Vijay H Shah
Journal:  J Clin Exp Hepatol       Date:  2011-11-09

Review 2.  Primary prophylaxis of esophageal variceal bleeding.

Authors:  Douglas A Simonetto; Vijay H Shah
Journal:  Clin Liver Dis (Hoboken)       Date:  2012-11-09

3.  Hemodynamic Response to Carvedilol is Maintained for Long Periods and Leads to Better Clinical Outcome in Cirrhosis: A Prospective Study.

Authors:  Vijendra Kirnake; Anil Arora; Varun Gupta; Praveen Sharma; Vikas Singla; Naresh Bansal; Mohan Goyal; Romesh Chawlani; Ashish Kumar
Journal:  J Clin Exp Hepatol       Date:  2016-01-23

Review 4.  Portal Hypertension and Cirrhosis: From Evolving Concepts to Better Therapies.

Authors:  Jaume Bosch
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-03-02

Review 5.  Evolution in the understanding of the pathophysiological basis of portal hypertension: How changes in paradigm are leading to successful new treatments.

Authors:  Jaume Bosch; Roberto J Groszmann; Vijay H Shah
Journal:  J Hepatol       Date:  2015-04       Impact factor: 25.083

Review 6.  Management of varices in patients with cirrhosis.

Authors:  Julia O'Brien; Christos Triantos; Andrew K Burroughs
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-04-02       Impact factor: 46.802

Review 7.  Pharmacologic prevention of variceal bleeding and rebleeding.

Authors:  Anna Baiges; Virginia Hernández-Gea; Jaime Bosch
Journal:  Hepatol Int       Date:  2017-12-05       Impact factor: 6.047

8.  A Randomized, Multi-Center, Open-Label Study to Evaluate the Efficacy of Carvedilol vs. Propranolol to Reduce Portal Pressure in Patients With Liver Cirrhosis.

Authors:  Sang G Kim; Tae Y Kim; Joo H Sohn; Soon H Um; Yeon S Seo; Soon K Baik; Moon Y Kim; Jae Y Jang; Soung W Jeong; Bora Lee; Young S Kim; Ki T Suk; Dong J Kim
Journal:  Am J Gastroenterol       Date:  2016-08-30       Impact factor: 10.864

9.  Austrian consensus on the definition and treatment of portal hypertension and its complications (Billroth II).

Authors:  Markus Peck-Radosavljevic; Bernhard Angermayr; Christian Datz; Arnulf Ferlitsch; Monika Ferlitsch; Valentin Fuhrmann; Michael Häfner; Ludwig Kramer; Andreas Maieron; Berit Payer; Thomas Reiberger; Rudolf Stauber; Rudolf Steininger; Michael Trauner; Siegfried Thurnher; Gregor Ulbrich; Wolfgang Vogel; Heinz Zoller; Ivo Graziadei
Journal:  Wien Klin Wochenschr       Date:  2013-04-12       Impact factor: 1.704

10.  Prevention and management of gastroesophageal varices in cirrhosis.

Authors:  Yen-I Chen; Peter Ghali
Journal:  Int J Hepatol       Date:  2012-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.